isoniazidiin
Isoniazid is a primary medication used in the prevention and treatment of tuberculosis. It is an antibiotic that works by inhibiting the synthesis of mycolic acids, which are essential components of the mycobacterial cell wall. Isoniazid is typically administered orally, though intramuscular injections are also an option.
The effectiveness of isoniazid against tuberculosis was first demonstrated in the early 1950s. It is often
Like all medications, isoniazid can have side effects. The most common adverse effects include peripheral neuropathy,
Isoniazid is a crucial tool in global public health efforts to control tuberculosis. Its accessibility and